164 related articles for article (PubMed ID: 37172637)
1. Multifunctional nano-system for multi-mode targeted imaging and enhanced photothermal therapy of metastatic prostate cancer.
Wang Z; Xing H; Liu A; Guan L; Li X; He L; Sun Y; Zvyagin AV; Yang B; Lin Q
Acta Biomater; 2023 Aug; 166():581-592. PubMed ID: 37172637
[TBL] [Abstract][Full Text] [Related]
2. AuNCs-LHRHa nano-system for FL/CT dual-mode imaging and photothermal therapy of targeted prostate cancer.
Wang Z; He L; Che S; Xing H; Guan L; Yang Z; Li X; Zvyagin AV; Lin Q; Qu W
J Mater Chem B; 2022 Jul; 10(27):5182-5190. PubMed ID: 35723067
[TBL] [Abstract][Full Text] [Related]
3. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Development of FL/MR dual-modal Au nanobipyramids for targeted cancer imaging and photothermal therapy.
Wang Y; Li M; Luo T; Jiao M; Jin S; Dou P; Zuo F; Wu C; Han C; Li J; Xu K; Zheng S
Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112190. PubMed ID: 34225846
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Gold Helix Phototheranostic Biohybrid That Enables Targeted Image-Guided Photothermal Therapy in Breast Cancer.
Hosseini M; Ahmadi Z; Kefayat A; Molaabasi F; Ebrahimpour A; Naderi Khojasteh Far Y; Khoobi M
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37447-37465. PubMed ID: 35943871
[TBL] [Abstract][Full Text] [Related]
7. A Highly Specific Multiple Enhancement Theranostic Nanoprobe for PET/MRI/PAI Image-Guided Radioisotope Combined Photothermal Therapy in Prostate Cancer.
Xia L; Meng X; Wen L; Zhou N; Liu T; Xu X; Wang F; Cheng Z; Yang Z; Zhu H
Small; 2021 May; 17(21):e2100378. PubMed ID: 33870644
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional nanoprobe for multi-mode imaging and diagnosis of metastatic prostate cancer.
Wang Z; Liu A; Li X; Guan L; Xing H; He L; Fang L; Zvyagin AV; Yang X; Yang B; Lin Q
Talanta; 2023 May; 256():124255. PubMed ID: 36652761
[TBL] [Abstract][Full Text] [Related]
9. MnCO
Lee KK; Lee JH; Lee SC; Lee CS
Theranostics; 2022; 12(15):6762-6778. PubMed ID: 36185599
[No Abstract] [Full Text] [Related]
10. Magnetite nanocluster@poly(dopamine)-PEG@ indocyanine green nanobead with magnetic field-targeting enhanced MR imaging and photothermal therapy in vivo.
Wu M; Wang Q; Zhang D; Liao N; Wu L; Huang A; Liu X
Colloids Surf B Biointerfaces; 2016 May; 141():467-475. PubMed ID: 26896652
[TBL] [Abstract][Full Text] [Related]
11. Magnetic-responsive and targeted cancer nanotheranostics by PA/MR bimodal imaging-guided photothermally triggered immunotherapy.
Guo Y; Ran Y; Wang Z; Cheng J; Cao Y; Yang C; Liu F; Ran H
Biomaterials; 2019 Oct; 219():119370. PubMed ID: 31357006
[TBL] [Abstract][Full Text] [Related]
12. A novel theranostic nano-platform (PB@FePt-HA-g-PEG) for tumor chemodynamic-photothermal co-therapy and triple-modal imaging (MR/CT/PI) diagnosis.
Hu Z; Wang S; Dai Z; Zhang H; Zheng X
J Mater Chem B; 2020 Jun; 8(24):5351-5360. PubMed ID: 32458958
[TBL] [Abstract][Full Text] [Related]
13. NIR-II-triggered photothermal therapy with Au@PDA/PEG-PI for targeted downregulation of PSMA in prostate cancer.
Ding X; Bai S; Liu F; Michał N; Roman S; Peng N; Liu Y
Acta Biomater; 2023 Feb; 157():487-499. PubMed ID: 36521678
[TBL] [Abstract][Full Text] [Related]
14. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
[TBL] [Abstract][Full Text] [Related]
15. Photothermal therapy: a novel potential treatment for prostate cancer.
Dong Z; Xue K; Verma A; Shi J; Wei Z; Xia X; Wang K; Zhang X
Biomater Sci; 2024 May; 12(10):2480-2503. PubMed ID: 38592730
[TBL] [Abstract][Full Text] [Related]
16. Au/Mn nanodot platform for
Yang Z; Zhao Y; Li Y; Song L; Lin Y; Liu K; Zhang Y; Zvyagin AV; Fang L; Sun Y; Yang B; Lin Q
J Mater Chem B; 2023 May; 11(21):4752-4762. PubMed ID: 37183453
[TBL] [Abstract][Full Text] [Related]
17. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
18. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
[TBL] [Abstract][Full Text] [Related]
19. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.
Hagiwara K; Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Tobisawa Y; Yoneyama T
Int Urol Nephrol; 2017 May; 49(5):811-816. PubMed ID: 28213801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
